Patents Assigned to VITAMFERO
  • Mutant strains of and uses thereof
    Patent number: 9603914
    Abstract: A mutant strain of Neospora spp, in which the function of the NcMIC3 protein and/or the function of the NcMIC1 protein is suppressed, and uses thereof in a pharmaceutical composition or in a vaccine composition.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: March 28, 2017
    Assignee: VITAMFERO
    Inventors: Anne-France Boussemart-Prouvost, Pascal Breton, Mauld Lamarque, Solen Morisse-Philippe, Edouard Seche
  • Use of attenuated strains of parasites for the prevention or treatment of pathologies associates with an apicomplexan
    Patent number: 9585949
    Abstract: Strains of Sarcocystidae selected from Toxoplasma spp or Neospora spp isolated from their natural environment and having an immunostimulant effect, for the use thereof in the prevention or the treatment, in a mammal, of a pathology associated with an apicomplexan of the family Cryptosporidiidae.
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: March 7, 2017
    Assignees: VITAMFERO, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE, UNIVERSITE FRANCOIS RABELAIS DE TOURS
    Inventors: Audrey Gnahoui-David, Fabrice Laurent, Marie-Noelle Mevelec, Edouard Seche